FDA Approves First 2 Drugs for Treatment of a Fatal Lung Disease
The first two drugs that can slow the progression of a fatal lung disease won approval from the Food and Drug Administration on Wednesday, a decision that could open a new era for patients but also a new chapter in the controversy over high drug prices.
New York Times - Wed, 15 Oct 2014 17:52

FDA Approves Two Drugs to Treat Deadly Lung Disease
Wall Street Journal - Wed, 15 Oct 2014 14:01

Two FDA Approvals on Same Day Renew Hope for Pulmonary Fibrosis ...
GlobeNewswire (press release) - Thu, 16 Oct 2014 07:46

Boehringer Ingelheim's OFEV™ (nintedanib*) approved by the FDA for the ...
Business Wire (press release) - Thu, 16 Oct 2014 02:11

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for ...
News-Medical.net - Wed, 15 Oct 2014 20:37

FDA Approves Two Drugs For Idiopathic Pulmonary Fibrosis
FXC News - Wed, 15 Oct 2014 18:52



Lung Infection Protection For Cystic Fibrosis Patients Could Be Developed From ...
Chronic lung diseases are a major medical condition throughout the world that is being exacerbated by pollution, smoking, and infections. In fact, the lung is a frequent target of infections, representing a significant risk for patients with chronic ...
Cystic Fibrosis News Today - Thu, 23 Oct 2014 06:52

FDA Approves Boehringer Ingelheim's Drug for Lung Disease
Pirfenidone idiopathic pulmonary fibrosis (IPF) drug molecule.Boehringer Ingelheim Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) approved OFEV (nintedanib) capsules for oral use for the treatment of idiopathic ...
Drug Discovery & Development - Thu, 16 Oct 2014 10:48

FDA Approves OFEV for the Treatment of Idiopathic Pulmonary Fibrosis
Pharmaceutical Technology Magazine - Fri, 17 Oct 2014 09:11



Program targets new care approach for lung patients
Kelly Ripplinger, respiratory therapist, Dr. Benjamin Morgan, medical director and Shari Durch, exercise physiologist will oversee a new local program this fall aimed at lung diseases. (Submitted photo) ...
River Falls Journal - Wed, 22 Oct 2014 14:00



Pulmonary Hypertension One of Several Lung Diseases Featuring Non Specific ...
As suspected by the authors at Hôpital européen Georges-Pompidou in France, non specific pattern (NSP) of lung function, also known as small airway obstruction syndrome, was identified in patients with lung diseases. Cases of NSP were numbered at 841 ...
Lung Disease News - Mon, 22 Sep 2014 08:02



Four New Drugs for Respiratory Diseases Receive Public Funding in New Zealand
PHARMAC The New Zealand Crown health agency, Pharmaceutical Management Agency (PHARMAC), has announced that funding four new medications tailored for the treatment of respiratory diseases, which may help more than 10,000 people in the ...
Lung Disease News - Tue, 21 Oct 2014 07:15



New Chronic Obstructive Pulmonary Disease Study To Test Novel Cell Therapy
shutterstock_130087466 A new pre-clinical study for Chronic Obstructive Pulmonary Disease (COPD) was recently announced by Cellular Biomedicine Group Inc. (CBMG). The company will employ human adipose-derived mesenchymal progenitor cell ...
Lung Disease News - Wed, 22 Oct 2014 10:48

Newly-Discovered Lung Defense Mechanism Against Bacteria Could Benefit CF ...
Patients with chronic lung diseases, such as chronic obstructive pulmonary disease (COPD), severe asthma, and cystic fibrosis have frequent bacterial infections in the lungs that can cause acute illness and a high mortality rate among these patients.
Lung Disease News - Fri, 24 Oct 2014 12:07


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014